Home › Targets › PI3Kα

PI3Kα (4 companies · 8 programs)

Companies with an active program directed at PI3Kα.

BridgeBio Oncology Therapeutics, Inc. BBOT

  • BBO-10203 — Colorectal Cancer Phase 1
  • BBO-10203 — Non-Small Cell Lung Cancer Phase 1
  • BBO-10203 — Pancreatic Ductal Adenocarcinoma Phase 1

Relay Therapeutics, Inc. RLAY

  • zovegalisib — Breast Cancer Phase 3
  • zovegalisib — PIK3CA-Related Overgrowth Spectrum Phase 2